Hisun Biologics Unit was established in 2003, employs over 600 technical personnel with expertise in developing and manufacturing of complex generic formulation and innovative biological drugs. Our state-of-the-art facilities, produce a diverse pipeline of products, including monoclonal antibodies, recombinant and fusion proteins, peptides, cell factors, vaccines, and antibody drug conjugations.
| No. | Product | Expression System | Indicatioin |
|---|---|---|---|
| 1 | Adalimumab | CHO cell | RA, AS |
| 2 | anti-CD20 Mab (Rituximab Bio-better) | CHO cell | Oncology |
| 3 | Denosumab | CHO cell | Oncology |
| 4 | Etanercept | CHO cell | RA, AS, Psoriasis |
| 5 | Infliximab | CHO cell | RA, IBD |
| 6 | Insulin Aspart | E.coli | Diabetes |
| 7 | Insulin Glargine | E.coli | Diabetes |
| 8 | Pertuzumab | CHO cell | Oncology |
| 9 | Recombinant Human Insulin | E.coli | Diabetes |
| 10 | Recombinant Interleukin -1Ra | E.coli | RA |
| 11 | Trastuzumab | CHO cell | Oncology |
| 12 | Tocilizumab | CHO cell | RA |